Saturday, November 16, 2024 2:58:14 PM
Purely as a hypothetical, let's say that 5 years ago LP met with the CEO and others from Merck and agreed that they'd sell 20% or NWBO's shares to them for $20 a share once NWBO's share price sustained a price over $10 for 30 consecutive days. This agreement was formalized.
Nothing material had actually yet occurred, NWBO could indicate a future intent to partner with a BP, but nothing need be revealed about a formal agreement having been reached.
It's likely the agreement would actually prevent any mention until certain terms have been met. My point is that things may happen years, even decades before key events occur that aren't announced until those key events occur. If they never occur it's as if they never happened.
I have no idea if anything like this exists, however I do believe that LP has informally established how highly she believes the company should be valued before she'd consider either an equity partner or buyout. The price for a buyout is probably substantially higher than that of an equity partnership.
I believe that the BP's know that she has sufficient control that a hostile bid at less than she'd take would be defeated, but would almost certainly drive the share price up substantially. I'm not suggesting that she has enough shares herself to insure this, but rather shares are in the hands of people she trusts to follow her guidance that she doesn't need to worry about a vote against what she recommends.
When IMGN was bought out, I was one of many who believed they sold to soon. It was clear they had the agreement of Institutions who owned the majority of the shares and a fight was useless.
Gary
Nothing material had actually yet occurred, NWBO could indicate a future intent to partner with a BP, but nothing need be revealed about a formal agreement having been reached.
It's likely the agreement would actually prevent any mention until certain terms have been met. My point is that things may happen years, even decades before key events occur that aren't announced until those key events occur. If they never occur it's as if they never happened.
I have no idea if anything like this exists, however I do believe that LP has informally established how highly she believes the company should be valued before she'd consider either an equity partner or buyout. The price for a buyout is probably substantially higher than that of an equity partnership.
I believe that the BP's know that she has sufficient control that a hostile bid at less than she'd take would be defeated, but would almost certainly drive the share price up substantially. I'm not suggesting that she has enough shares herself to insure this, but rather shares are in the hands of people she trusts to follow her guidance that she doesn't need to worry about a vote against what she recommends.
When IMGN was bought out, I was one of many who believed they sold to soon. It was clear they had the agreement of Institutions who owned the majority of the shares and a fight was useless.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
